A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL OF INTRAVITREOUS BEVACIZUMAB VERSUS TRIAMCINOLONE IN PATIENTS WITH DIABETIC MACULAR OEDEMA UNDERGOING CATARACT SURGERY (THE DIMECAT TRIAL)-6-MONTH RESULTS

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY(2018)

引用 2|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要